shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21)

    RFA-OH-24-002

    Centers for Disease Control and Prevention - ERA

    Opening date 18 Aug 2023, 12:00AM

    Closing date 5 Dec 2023, 12:00AM

    Funding Opportunity Number: RFA-OH-24-002

    Opportunity Category: Discretionary

    Expected Number of Awards: 8

    CFDA Number(s): 93.262 -- Occupational Safety and Health Program

    Cost Sharing or Matching Requirement: No

    Posted Date: Aug 18, 2023 12:00:00 AM EDT

    Closing Date: Dec 05, 2023 12:00:00 AM EST

    Closing Date Details: Electronically submitted applications must be submitted no later than 5:00 pm ET on the listed application due date.

    Estimated Total Program Funding: 4000000

    Eligible Applicants: County governments,Small businesses,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,For profit organizations other than small businesses,Private institutions of higher education,Independent school districts,Special district governments,Public and State controlled institutions of higher education,Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility",Native American tribal governments (Federally recognized),State governments,City or township governments,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments)

    Additional Information on Eligibility: N/A

    Agency Name: Centers for Disease Control and Prevention - ERA

    Description: NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals receiving monitoring and/or treatment under subtitle B of the James Zadroga 9/11 Health and Compensation Act of 2010 (Public Law 111–347, as amended by Public Laws 114–113, 116–59 and 117-328). World Trade Center (WTC) responders, screening-eligible WTC survivors, and certified-eligible WTC survivors comprise the population targeted for the research project.Lifestyle medicine is a highly valuable, evidence-informed clinical approach focused on preventing, managing, and reversing many types of chronic diseases certified as WTC-related health conditions by the WTC Health Program. By focusing on sustainable health behaviors and lifestyle factors (including these 6 pillars: nutrition and diet, sleep hygiene, stress management and positive psychology, physical activity, social connectedness, and avoidance of harmful substance use), lifestyle medicine has the potential to: limit current disease progression, prevent development of additional chronic diseases, and improve health outcomes, overall member well-being, quality of life, and member satisfaction with the Program.To help maximize the impact of the WTC Health Program FY2024 lifestyle medicine research, NIOSH seeks to achieve a suitable mix of projects and interventions focusing on sustainable health behaviors and the lifestyle factors described previously. All these sustainable health behaviors and lifestyle factors influence disease progression and recurrence, survival, quality of life, and other health-related outcomes among the 9/11-exposed population. Research funded by the WTC Health Program is primarily intended for the benefit of the 9/11-exposed population. It is not required that project findings be generalizable to other populations.The NIOSH/WTC Health Program R21 grant is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development which assess the feasibility of new areas of investigation with the potential to enhance treatment effectiveness and diagnostic practices. These studies may lead to breakthroughs in a particular area, or to the development of new techniques, agents, methodologies, models, or approaches with major clinical impacts. These studies are expected to break new ground or extend prior discoveries toward new directions or uses. Applicants are expected to propose research approaches for which there is likely to be minimal or no preliminary data.The WTC Health Program Research webpage provides comprehensive information and tools for researchers. The research agenda, publication library, and other resources, including the Funding Dashboard, can also be found there (e.g., awarded project details such as publications, topics, populations, funding awarded, and the principal investigators and their institutions).

    Grantor Contact Information: James Yiin, PhD, Scientific Program Official JYiin@cdc.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept